ZGOO Holdings Co., Ltd. (KOSDAQ:221800)
South Korea · Delayed Price · Currency is KRW 4,855.00
+335.00 (7.41%)
At close: Jul 23, 2026
ZGOO Holdings Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '14 Dec 31, 2014 |
Revenue Revenue Growth | 25,593 | 25,593 | 25,040 | 30,792 | 69,013 | 11,002 |
Revenue Growth | 2.21% | 2.21% | -18.68% | -55.38% | 527.29% | 16.90% |
Gross Profit Gross Profit Growth | 5,394 | 5,394 | 5,039 | 8,219 | 26,639 | 2,867 |
Operating Income Operating Income Growth | -2,192 | -2,192 | -2,928 | -1,338 | 15,708 | 685.8 |
Net Income Net Income Growth | -1,642 | -1,642 | -2,840 | 645.9 | 13,160 | 271.68 |
Earnings Per Share EPS Growth | -141.22 | -141.22 | -252.00 | 63.00 | 1303.00 | 188.00 |
EPS Growth | - | - | - | -95.17% | 593.09% | 62.07% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
General Diagnostic Examination General Diagnostic Examination Growth | 11,472 | 10,830 | 11,069 |
General Diagnostic Test Reagents, Etc. General Diagnostic Test Reagents, Etc. Growth | 7,567 | 7,175 | - |
Molecular Diagnostic Testing Molecular Diagnostic Testing Growth | 2,207 | 4,437 | 24,954 |
Medical Information Technology Solutions Service Medical Information Technology Solutions Service Growth | 1,135 | 1,762 | 1,689 |
Molecular Diagnostic Test Reagents, Etc. Molecular Diagnostic Test Reagents, Etc. Growth | 65.01 | 2,236 | - |
Medical Information Technology Solutions Merchandise Medical Information Technology Solutions Merchandise Growth | 40.42 | 54.65 | - |
Other Other Growth | 2,555 | 4,298 | 1,738 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '14 Dec 31, 2014 |
Cash & Investments Cash & Investments Growth | 31,767 | 31,767 | 33,991 | 36,792 | 36,921 | 1,006 |
Total Debt Total Debt Growth | 442.62 | 442.62 | 458.06 | 452.27 | 521.59 | 4,379 |
Net Cash (Debt) Net Cash Growth | 31,324 | 31,324 | 33,533 | 36,340 | 36,400 | -3,373 |
Net Cash Growth | -6.59% | -6.59% | -7.72% | -0.17% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 2694.02 | 2694.02 | 2974.91 | 3544.53 | 3604.03 | -2333.98 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '14 Dec 31, 2014 |
Operating Cash Flow Operating Cash Flow Growth | -1,562 | -1,562 | -1,731 | -2,555 | 24,406 | -986.6 |
Capital Expenditures CapEx Growth | -91.62 | -91.62 | -43.39 | -214.43 | -967.1 | -495.43 |
Free Cash Flow Free Cash Flow Growth | -1,654 | -1,654 | -1,775 | -2,769 | 23,439 | -1,482 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '14 Dec 31, 2014 |
Gross Margin | 21.08% | 21.08% | 20.13% | 26.69% | 38.60% | 26.05% |
Operating Margin | -8.56% | -8.56% | -11.69% | -4.35% | 22.76% | 6.23% |
Pretax Margin | -5.17% | -5.17% | -6.47% | 0.12% | 23.28% | 2.47% |
Profit Margin | -6.42% | -6.42% | -11.34% | 2.10% | 19.07% | 2.47% |
FCF Margin | -6.46% | -6.46% | -7.09% | -8.99% | 33.96% | -13.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2014 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '14 Dec 31, 2014 |
PE Ratio | - | - | - | 92.27 | 3.75 | - |
P/FCF Ratio | - | - | - | - | 2.10 | - |
PS Ratio | 3.10 | 2.08 | 1.20 | 1.94 | 0.72 | - |